Developers and investors

Interview with Charles Walford, Senior Development Director and Head of Life Sciences at Stanhope

Charles Walford, Senior Development Director & Head of Life Sciences at Stanhope
Charles Walford, Senior Development Director & Head of Life Sciences at Stanhope
Table of Contents
In: Developers and investors

Stanhope is a London based developer and asset manager with over 30 years’ experience of delivering high quality developments that optimise value for its partners and the local communities it served. Stanhope is known for its strong partnership approach and innovative responses to complex urban development opportunities with specific expertise in London.

It has delivered 2.8 million sqm(30 million sq ft) & €47 billion(£40 billion) of end value, typically managing around €3.5 billion(£3 billion) of construction projects.

Stanhope’s first involvement in the life sciences sector was in 2014 with the refurbishment and extension of One Mabledon Place, a 10-storey, 8,360 sqm (90,000 sq ft) office building adjacent to the King’s Cross Knowledge Quarter.

The building was let to The Doctor’s Laboratory, the largest UK independent provider of specialised pathology clinical laboratory services to clinicians, hospitals and community health services.This triggered research into the emerging demand from life science occupiers for urban locations and led to projects including the British Library extension and Royal Street in London and, more recently,Oxford North.

We caught up with Charles Walford, Senior Development Director and Head of Life Sciences.

More from Life Sciences Real Estate

Stay on top of the life sciences real estate markets in Europe

Join us
Great! You’ve successfully signed up.
Welcome back! You've successfully signed in.
You've successfully subscribed to Life Sciences Real Estate.
Your link has expired.
Success! Check your email for magic link to sign-in.
Success! Your billing info has been updated.
Your billing was not updated.